IIM
TARS icon

INTECH Investment Management’s Tarsus Pharmaceuticals TARS Stock Holding History

INTECH Investment Management’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$609K Buy
9,677
+194
+2% +$12.4K 0.01% 1259
2026
Q1 		$665K Sell
9,483
-4,340
-31% -$303K 0.01% 1204
2025
Q4 		$1.13M Hold
13,823
– – 0.01% 1065
2025
Q3 		$822K Sell
13,823
-3,486
-20% -$172K 0.01% 1291
2025
Q2 		$701K Buy
17,309
+1,918
+12% +$86.3K 0.01% 1413
2025
Q1 		$791K Buy
15,391
+710
+5% +$35.1K 0.01% 1344
2024
Q4 		$813K Buy
14,681
+6,109
+71% +$277K 0.01% 1273
2024
Q3 		$282K Buy
+8,572
New +$241K ﹤0.01% 1547

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

INTECH Investment Management's TARS Position: Q2 2026 in Review

INTECH Investment Management increased its Tarsus Pharmaceuticals (TARS) stake by 2% in Q2 2026, buying an estimated $12.4K and bringing the position to 9,677 shares worth $609K. The position accounts for 0.01% of the portfolio, ranked #1259.

INTECH Investment Management first reported a position in TARS in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.13M in Q4 2025. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • INTECH Investment Management held 9,677 shares of Tarsus Pharmaceuticals worth $609K as of Q2 2026.
  • INTECH Investment Management bought 194 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $12.4K.
  • Tarsus Pharmaceuticals made up 0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1259 holding.
  • INTECH Investment Management first reported a position in Tarsus Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • INTECH Investment Management's Tarsus Pharmaceuticals position peaked at $1.13M in Q4 2025.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.